España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
LAVA Therapeutics
LVTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.57
-0.09
-5.42%
At close: -
$1.61
0.04
2.55%
After Hours: Nov 13, 5:41 AM EDT
Get Report
Comment
LAVA Therapeutics (LVTX) Forecast
News
Earnings
LAVA Therapeutics (LVTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for LAVA Therapeutics (NASDAQ:LVTX) Stock
LAVA Therapeutics Stock (NASDAQ: LVTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, August 21, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Tuesday, August 20, 2024
LAVA Therapeutics Q2 EPS $(0.31) Up From $(0....
Benzinga Newsdesk
Friday, June 28, 2024
HC Wainwright & Co. Reiterates Buy on LAVA Th...
Benzinga Newsdesk
Tuesday, May 21, 2024
LAVA Therapeutics Q1 EPS $(0.02) Beats $(0.12...
Benzinga Newsdesk
Thursday, March 21, 2024
HC Wainwright & Co. Reiterates Buy on LAVA Th...
Benzinga Newsdesk
Wednesday, March 20, 2024
LAVA Therapeutics Q4 EPS $(0.24) Misses $(0.1...
Benzinga Newsdesk
Tuesday, March 05, 2024
LAVA Therapeutics shares are trading higher a...
Benzinga Newsdesk
LAVA Therapeutics Announces Pfizer Has Achiev...
Benzinga Newsdesk
Thursday, February 29, 2024
LAVA Therapeutics N.V Filed U.S. Patent Appli...
Benzinga Newsdesk
Watching LAVA Therapeutics N.V.; Shares Spike...
Benzinga Newsdesk
Friday, January 26, 2024
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet (Donald Trump Has Re-Entered The Chat)
Chris Katje
Thursday, January 25, 2024
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat Results
Avi Kapoor
LAVA Therapeutics shares are trading higher a...
Benzinga Newsdesk
Dow Surges Over 100 Points; US GDP Growth Tops Estimates
Avi Kapoor
Why Is Cancer Focused LAVA Therapeutics Nano Cap Stock Trading Higher Today?
Vandana Singh
Market-Moving News for January 25th
Benzinga Newsdesk
LAVA Therapeutics Partners With Merck To Eval...
Benzinga Newsdesk
Friday, November 17, 2023
HC Wainwright & Co. Reiterates Buy on LAVA Th...
Benzinga Newsdesk
Thursday, November 16, 2023
As Of September 30, 2023, Lava Therapeutics H...
Benzinga Newsdesk
LAVA Therapeutics Q3 EPS $(0.34) Down From $0...
Benzinga Newsdesk
Wednesday, August 23, 2023
What 5 Analyst Ratings Have To Say About LAVA Therapeutics
Benzinga Insights
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on LAVA The...
Benzinga Newsdesk
Tuesday, August 22, 2023
LAVA Therapeutics Q2 EPS $(0.48) Misses $(0.4...
Benzinga Newsdesk
Thursday, June 15, 2023
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Wednesday, June 14, 2023
LAVA Therapeutics Provides Updates On Clinica...
Benzinga Newsdesk
Monday, June 12, 2023
HC Wainwright & Co. Reiterates Buy on LAVA Th...
Benzinga Newsdesk
Friday, June 09, 2023
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Thursday, June 08, 2023
Recap: LAVA Therapeutics Q1 Earnings
Benzinga Insights
LAVA Therapeutics Q1 EPS $(0.53) Misses $(0.5...
Benzinga Newsdesk
Friday, June 02, 2023
Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
LAVA Therapeutics shares are trading higher a...
Benzinga Newsdesk
High-Impact Movers for June 2nd
Benzinga Newsdesk
Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Thursday, June 01, 2023
LAVA Therapeutics Announces Selection By Janssen Of Lead Gamma-Delta T-Cell Engager Bispecific Antibody To Move Toward Clinical Development
Happy Mohamed
Thursday, April 13, 2023
HC Wainwright & Co. Reiterates Buy on LAVA Th...
Benzinga Newsdesk
Wednesday, March 15, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Friday, February 17, 2023
HC Wainwright & Co. Reiterates Buy on LAVA Th...
Benzinga Newsdesk
Thursday, February 16, 2023
LAVA Therapeutics Announced Initial Data from the Ongoing Phase 1/2a Clinical Trial of LAVA-1207 in Therapy Refractory mCRPC at the 2023 ASCO GU Symposium
Charles Gross
Wednesday, December 14, 2022
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
Lisa Levin
Wednesday, November 16, 2022
LAVA Therapeutics Q3 EPS $0.04 Up From $(0.27...
Benzinga Newsdesk
Tuesday, November 01, 2022
LAVA Therapeutics Announces Appointment Of Fr...
Benzinga Newsdesk
Tuesday, October 25, 2022
Analyst Says This Small Cap Stock Might Be 'Game Changer' In Bispecific T Cell Engagers Space
Vandana Singh
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022
Benzinga Insights
HC Wainwright & Co. Initiates Coverage On LAV...
Benzinga Newsdesk
Friday, October 07, 2022
Lava Therapeutics To Present On-Mechanism Pha...
Benzinga Newsdesk
Tuesday, September 27, 2022
Snap To Surge Around 20%? Here Are 5 Other Price Target Changes For Tuesday
Lisa Levin
Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday
Lisa Levin
Show More